Mt. Desiato et Md. Caramia, TOWARDS A NEUROPHYSIOLOGICAL MARKER OF AMYOTROPHIC-LATERAL-SCLEROSIS AS REVEALED BY CHANGES IN CORTICAL EXCITABILITY, ELECTROMYOGRAPHY AND MOTOR CONTROL-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 105(1), 1997, pp. 1-7
Motor evoked potentials (MEPs) to magnetic trans cranial stimulation (
TCS) were recorded in 47 patients with amyotrophic lateral sclerosis (
ALS) in order to evaluate both excitability and conductivity changes r
elating to central motor pathways. The results were compared with thos
e obtained from a control population of 43 subjects, 34 patients with
definite multiple sclerosis (MS) and 15 patients with a rigid early fo
rm of Parkinson's disease (PD). The excitability threshold to TCS was
higher in ALS patients for both upper and lower limbs compared with bo
th controls and PD patients, but lower than that of MS patients. The S
ilent Period duration (SP (hand recordings): 80.1 ms, SD: 38.5) was si
gnificantly shorter in ALS patients than in all the other examined sub
jects (P < 0.001), nor did it increase proportionally to TCS intensity
as with control subjects. The abnormal behavior of the SP appears to
be specifically linked to the ALS disease, since it was neither observ
ed in PD patients, nor in those with multiple sclerosis, who, on the c
ontrary, displayed a prolonged mean duration of the SP (161.6 ms, SD 7
7 vs. 115.7 ms, SD 62 for the control group). Due to the neuronal loss
of the largest neurons in ALS, MEP latency, amplitude, duration and t
he motor central conduction time (CCT) were in different proportion fo
und abnormal. Our study shows how different neurological diseases with
central motor involvement share broadly similar MEP abnormalities, bu
t a different involvement of the silent period. We suggest that in ALS
patients there may be abnormalities of motor cortical inhibitory mech
anisms which are detected with the measurement of the SP. The distinct
ive 'depression' of this parameter in the case of ALS could be a signi
ficant marker for diagnosing this disease. (C) 1997 Elsevier Science I
reland Ltd.